A group of nerve cells essential for cognition may be especially vulnerable to DNA damage upon exposure to inflammation in MS.

Certain MS-driving immune cells express a protein marker called CD29, which helps these cells move into the brain and trigger inflammation.

Quantum Biopharma has filed with the FDA to start a Phase 2 trial of Lucid-MS to assess the treatment's ability to halt ...

As Jenn Powell's MS progression continues, she's had to make the difficult decision to step away from the stress of full-time ...

Funded by the National Multiple Sclerosis Society, the study aims to identify care gaps and develop resources for women with ...

MS Canada is inviting cyclists across the country to take part in its 2026 MS Bike season and raise funds for the MS ...

MS cases have doubled in England over the past two decades, but people diagnosed more recently are living longer, data show.

The ACP received funding to help interpret research and support decisions about MS treatments for older adults with MS.

A study found brain atrophy progresses more slowly with age in RRMS, highlighting the need to factor age into MS clinical ...

The cells that line the inside of the gut may play a key role in triggering inflammation that drives MS, a study found.

Privosegtor has received PRIME designation in Europe for the treatment of optic neuritis, a condition commonly seen in ...

A new, lifelike model of nerve fibers may serve as a platform to screen for experimental treatments that can promote myelin ...